drugset / Trial / NCT03004365
A Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Dental Subjects
RandomizedSequentialSingle-blindTreatment
Summary
The purpose of this single-blind study is to evaluate whether C16G2 Varnish administered in multiple doses can effectively kill the bacteria in the oral cavity that cause dental caries.
Timeline
- Start
- 2017-01-27
- Primary completion
- 2017-03-29
- Completion
- 2017-03-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | C16G2 | Peptide | 13.6 mg | Topical |
| Comparator | C16G2 | Peptide | 27.2 mg | Topical |
| Comparator | C16G2 | Peptide | 54.4 mg | Topical |